Search Results 581-590 of 16335 for monoclonal antibody
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
... monoclonal antibody therapy must have completed that therapy ≥ 6 weeks (or 3 half-lives of the antibody, whichever is shorter) prior to enrollment on ...
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic body radiation therapy is a ...
The purpose of this study is to evaluate the safety and drug/body interactions of ABBV-085, and to determine the recommended future study dose (alone or in ...
... Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas Scottsdale/Phoenix, AZ; Rochester, MN. The purpose of this study is to evaluate ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...
Specialized testing at Mayo Clinic revealed he had GFAP-IgG associated autoimmune encephalitis. Once this rarer antibody was identified, Spencer could begin ...
... antibody barriers to immediate and long-term transplant success. One example of these barriers is the action of antibodies against human leukocyte antigens ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.